Annexon, Inc. (ANNX)
4.535
-0.14
(-2.89%)
USD |
NASDAQ |
Sep 09, 10:30
Annexon 1 Year Total Returns (Daily) : 111.3% for Sept. 8, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| September 08, 2026 | 111.3% |
| September 04, 2026 | 126.5% |
| September 03, 2026 | 136.1% |
| September 02, 2026 | 138.2% |
| September 01, 2026 | 137.4% |
| August 31, 2026 | 139.8% |
| August 28, 2026 | 134.4% |
| August 27, 2026 | 148.8% |
| August 26, 2026 | 132.1% |
| August 25, 2026 | 139.5% |
| August 24, 2026 | 119.0% |
| August 21, 2026 | 133.6% |
| August 20, 2026 | 142.1% |
| August 19, 2026 | 151.1% |
| August 18, 2026 | 124.7% |
| August 17, 2026 | 110.2% |
| August 14, 2026 | 122.3% |
| August 13, 2026 | 102.3% |
| August 12, 2026 | 118.4% |
| August 11, 2026 | 127.2% |
| August 10, 2026 | 128.4% |
| August 07, 2026 | 128.3% |
| August 06, 2026 | 138.3% |
| August 05, 2026 | 116.5% |
| August 04, 2026 | 110.7% |
| Date | Value |
|---|---|
| August 03, 2026 | 114.3% |
| July 31, 2026 | 112.3% |
| July 30, 2026 | 103.5% |
| July 29, 2026 | 104.2% |
| July 28, 2026 | 99.60% |
| July 27, 2026 | 104.4% |
| July 24, 2026 | 104.7% |
| July 23, 2026 | 113.7% |
| July 22, 2026 | 120.7% |
| July 21, 2026 | 118.2% |
| July 20, 2026 | 140.1% |
| July 17, 2026 | 147.9% |
| July 16, 2026 | 145.4% |
| July 15, 2026 | 160.0% |
| July 14, 2026 | 112.6% |
| July 13, 2026 | 118.2% |
| July 10, 2026 | 107.1% |
| July 09, 2026 | 114.4% |
| July 08, 2026 | 119.9% |
| July 07, 2026 | 135.5% |
| July 06, 2026 | 106.2% |
| July 02, 2026 | 94.31% |
| July 01, 2026 | 124.7% |
| June 30, 2026 | 137.9% |
| June 29, 2026 | 131.1% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Marker Therapeutics, Inc. | 46.40% |
| Krystal Biotech, Inc. | 141.9% |
| Immix Biopharma, Inc. | 510.6% |
| ACADIA Pharmaceuticals, Inc. | 8.63% |
| Alnylam Pharmaceuticals, Inc. | -42.84% |